Synthesis and biological evaluation of esterified and acylated derivatives of NH2-(AEEA)5-amphotericin B


  • 1.

    Oura M, Sternberg TH, Wright ET. A new antifungal antibiotic, amphotericin B. Antibiot Annu. 1956;3:566–73.

  • 2.

    Donovick R, Gold W, Pagano JF, Stout HA. Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. Antibiot Annu. 1956;3:579–86.

    CAS 

    Google Scholar
     

  • 3.

    Saravolatz LD, Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH. Amphotericin B: time for a new “gold standard”. Clin Infect Dis. 2003;37:415–25.

    Article 

    Google Scholar
     

  • 4.

    Bartner E, Zinnes H, Moe RA, Kulesza JS. Studies on a new solubilized preparation of amphotericin B. Antibiot Annu. 1957;5:53–8.

    PubMed 

    Google Scholar
     

  • 5.

    Deray G. Amphotericin B nephrotoxicity. J Antimicrob Chemother. 2002;9:37–41.

    Article 

    Google Scholar
     

  • 6.

    Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J Chemother. 2000;12:463–70.

    CAS 
    Article 

    Google Scholar
     

  • 7.

    Laniado-Laborín R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev Iberoam Micol. 2009;26:223–7.

    Article 

    Google Scholar
     

  • 8.

    Dupont B. Overview of the lipid formulations of amphotericin B. J Antimicrob Chemother. 2002;49:31–6.

    CAS 
    Article 

    Google Scholar
     

  • 9.

    Hartsel SC, Baas B, Bauer E, Foree LT, Kindt K, Preis H, et al. Heat-induced super-aggregation of amphotericin B modifies its interaction with serum proteins and lipoproteins and stimulation of TNF-alpha. J Pharm Sci. 2001;90:124–33.

    CAS 
    Article 

    Google Scholar
     

  • 10.

    Bonner DP, Mechlinski W, Schaffner CP. Polyene macrolide derivatives. 3. Biological properties of polyene macrolide ester salts. J Antibiot. 1972;25:261.

    CAS 
    Article 

    Google Scholar
     

  • 11.

    Grzybowska J, Sowiński P, Gumieniak J, Zieniawa T, Borowski E. N-methyl-N-D-fructopyranosylamphotericin B methyl ester, new amphotericin B derivative of low toxicity. J Antibioti. 2006;50:709–11.

    Article 

    Google Scholar
     

  • 12.

    Hąc-Wydro K, Dynarowicz-Łątka P, Grzybowska J, Borowski E. N-(1-piperidinepropionyl) amphotericin B methyl ester (PAME)-a new derivative of the antifungal antibiotic amphotericin B: searching for the mechanism of its reduced toxicity. J Colloid Interface Sci. 2005;287:476–84.

    Article 

    Google Scholar
     

  • 13.

    And VP, Carreira EM. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine. Org Lett. 2006;8:1807–9.

    Article 

    Google Scholar
     

  • 14.

    Zhang JH, Ma J, Dong YZ, Zhao WJ, Feng J. Synthesis and characterization of NH2-(AEEA)n-amphotericin B derivatives. J Antibiot. 2019;72:210–7.

    CAS 
    Article 

    Google Scholar
     

  • 15.

    Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller MA, et al. Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. J Clin Microbiol. 2005;43:5243.

    CAS 
    Article 

    Google Scholar
     

  • 16.

    Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Chemother. 1998;42:1207–12.

    CAS 
    Article 

    Google Scholar
     

  • 17.

    Bulmus V, Woodward M, Lin L, Murthy N, Stayton P, Hoffman A. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J Control Release. 2003;93:105–20.

    CAS 
    Article 

    Google Scholar
     

  • 18.

    Higuchi TA, Connors KA. Phase-solubility techniques. In: Advances in analytical chemistry and instrumentation. Manhattan, USA: Jonh Wiley & Sons, INC; 1965.

  • 19.

    Jouyban A. Handbook of solubility data for pharmaceuticals. Vol. 3. Florida, USA: CRC Press; 2010. p. 198–202.

  • 20.

    Slisz M, Cybulska B, Mazerski J, Grzybowska J, Borowski E. Studies of the effects of antifungal cationic derivatives of amphotericin B on human erythrocytes. J Antibiot. 2004;57:669–78.

    CAS 
    Article 

    Google Scholar
     

  • 21.

    Itai B, Nir O, Vladimir D, Alex MS. Amphotericin B derivatives. USA, US20170319705A1. 2017.

  • 22.

    Barwicz J, Christian S, Gruda I. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob Agents Chemother. 1992;36:2310–5.

    CAS 
    Article 

    Google Scholar
     



  • Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *